Shares of Corbus Pharmaceuticals Holdings Inc. CRBP rallied 3.38% to $5.20 Wednesday, on what proved to be an all-around ...
We are excited to welcome Dr. Vincent, whose extensive drug development experience and expertise in translating groundbreaking science into therapies will be instrumental in leading our scientific ...
In a report released today, Yaron Werber from TD Cowen maintained a Buy rating on Forte Biosciences (FBRX – Research Report). The company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback